The relationship between B-type natriuretic peptide, heart structure, and function in 4,300 patients with heart failure enrolled to Val-HeFT

Roberto Latini; Serge Masson; Lidia Staszewsky; Aldo Maggioni; Alberto Volpi; Simona Barlera; Inder S. Anand; Allen Hester; Maylene Wong; Jay N. Cohn

doi:10.1016/s0735-1097(03)81613-3

Back

The relationship between B-type natriuretic peptide, heart structure, and function in 4,300 patients with heart failure enrolled to Val-HeFT

Article 2003 en

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2003

Changes in Brain Natriuretic Peptide and Norepinephrine Over Time and Mortality and Morbidity in the Valsartan Heart Failure Trial (Val-HeFT)

Inder S. Anand, Lloyd D. Fisher, YannTong Chiang, Roberto Latini, Serge Masson, Aldo Maggioni, Robert Glazer, Gianni Tognoni, Jay N. Cohn

Article2006

Statins and symptomatic chronic systolic heart failure: A post-hoc analysis of 5010 patients enrolled in Val-HeFT

Henry Krum, Roberto Latini, Aldo Maggioni, Inder S. Anand, Serge Masson, Elisa Carretta, Franco Ingrillì, Giacinto Pettinati, Robert Glazer, Gianni Tognoni, Jay N. Cohn

Article2003

Changes in plasma brain natriuretic peptide and norepinephrine over time and subsequent mortality and morbidity in heart failure: Results from Val-HeFT

Inder S. Anand, Lloyd D. Fisher, Yann-Tom Chiang, Roberto Latini, Serge Masson, Aldo Maggioni, Robert Glazer, Gianni Tognoni, Jay N. Cohn

Article2006

Incremental Prognostic Value of Changes in B-Type Natriuretic Peptide in Heart Failure

Roberto Latini, Serge Masson, Maylene Wong, Simona Barlera, Elisa Carretta, Lidia Staszewsky, T. Vago, Aldo Maggioni, Inder S. Anand, Lip Bun Tan, Gianni Tognoni, Jay N. Cohn

Article2005

Valsartan Reduces the Incidence of Atrial Fibrillation in Patients With Heart Failure: Results From the Valsartan Heart Failure Trial (Val-HeFT)

Aldo Maggioni, Roberto Latini, Peter E. Carson